Clinical Trial Update: A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating HRS-4508 in combination with other antitumor therapies for locally advanced or metastatic non-small ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HRS-4508

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Lung Cancer | Phase 2 | Status: RECRUITING